Breast cancer cure rates almost doubled in combo therapy trial A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost doubled – the cure rate for patients with the most common kind of breast...

Recent trials show that combining immunotherapy with chemotherapy nearly doubled breast cancer cure rates. This innovative approach could shift treatment paradigms significantly. https://bit.ly/4azjyUO
#BreastCancerCure #ImmunotherapyBreakthrou…